398 related articles for article (PubMed ID: 25998889)
1. Angiotensin-Converting Enzyme 2 Attenuates Bleomycin-Induced Lung Fibrosis in Mice.
Wang L; Wang Y; Yang T; Guo Y; Sun T
Cell Physiol Biochem; 2015; 36(2):697-711. PubMed ID: 25998889
[TBL] [Abstract][Full Text] [Related]
2. Osthole Alleviates Bleomycin-Induced Pulmonary Fibrosis via Modulating Angiotensin-Converting Enzyme 2/Angiotensin-(1-7) Axis and Decreasing Inflammation Responses in Rats.
Hao Y; Liu Y
Biol Pharm Bull; 2016; 39(4):457-65. PubMed ID: 26822530
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
4. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin-angiotensin system in the lung.
Chang J; Nie H; Ge X; Du J; Liu W; Li X; Sun Y; Wei X; Xun Z; Li YC
Sci Rep; 2021 Aug; 11(1):16525. PubMed ID: 34400742
[TBL] [Abstract][Full Text] [Related]
6. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
7. Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis.
Conte E; Iemmolo M; Fruciano M; Fagone E; Gili E; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
Expert Opin Biol Ther; 2015; 15 Suppl 1():S211-21. PubMed ID: 26098610
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of angiotensin-converting enzyme 2 overexpression improving collagen synthesis in lung].
Yang QJ; Zheng BB; Sun NN; Pan MX; Zheng ZM; Meng Y
Zhonghua Yi Xue Za Zhi; 2017 Mar; 97(10):770-776. PubMed ID: 28316159
[No Abstract] [Full Text] [Related]
9. N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice.
Li S; Li Y; Zhang Y; Li S; Zhang M; Jin F; Wei Z; Yang Y; Gao X; Mao N; Ge X; Xu H; Yang F
Toxicol Appl Pharmacol; 2020 Dec; 408():115255. PubMed ID: 33007385
[TBL] [Abstract][Full Text] [Related]
10. Protective role of andrographolide in bleomycin-induced pulmonary fibrosis in mice.
Zhu T; Zhang W; Xiao M; Chen H; Jin H
Int J Mol Sci; 2013 Dec; 14(12):23581-96. PubMed ID: 24300094
[TBL] [Abstract][Full Text] [Related]
11. Obaculactone protects against bleomycin-induced pulmonary fibrosis in mice.
Wang X; Ouyang Z; You Q; He S; Meng Q; Hu C; Wu X; Shen Y; Sun Y; Wu X; Xu Q
Toxicol Appl Pharmacol; 2016 Jul; 303():21-29. PubMed ID: 27180239
[TBL] [Abstract][Full Text] [Related]
12. The role of high mobility group box1 in pulmonary fibrosis.
Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
[TBL] [Abstract][Full Text] [Related]
13. siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats.
Zhang YP; Li WB; Wang WL; Liu J; Song SX; Bai LL; Hu YY; Yuan YD; Zhang M
Acta Pharmacol Sin; 2012 Jul; 33(7):897-908. PubMed ID: 22659625
[TBL] [Abstract][Full Text] [Related]
14. Corilagin attenuates aerosol bleomycin-induced experimental lung injury.
Wang Z; Guo QY; Zhang XJ; Li X; Li WT; Ma XT; Ma LJ
Int J Mol Sci; 2014 May; 15(6):9762-79. PubMed ID: 24886817
[TBL] [Abstract][Full Text] [Related]
15. Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice.
Liu W; Wan J; Han JZ; Li C; Feng DD; Yue SJ; Huang YH; Chen Y; Cheng QM; Li Y; Luo ZQ
Respir Res; 2013 Oct; 14(1):101. PubMed ID: 24098933
[TBL] [Abstract][Full Text] [Related]
16. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.
Tabata C; Tabata R; Kadokawa Y; Hisamori S; Takahashi M; Mishima M; Nakano T; Kubo H
J Immunol; 2007 Jul; 179(1):708-14. PubMed ID: 17579094
[TBL] [Abstract][Full Text] [Related]
18. Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis.
Li X; Molina-Molina M; Abdul-Hafez A; Ramirez J; Serrano-Mollar A; Xaubet A; Uhal BD
Am J Physiol Lung Cell Mol Physiol; 2006 Nov; 291(5):L887-95. PubMed ID: 16844946
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology Study of the Multiple Angiogenesis Inhibitor RC28-E on Anti-Fibrosis in a Chemically Induced Lung Injury Model.
Kou X; Sun Y; Li S; Bian W; Liu Z; Zhang D; Jiang J
Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31652997
[TBL] [Abstract][Full Text] [Related]
20. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
